PACS Group Receives Consensus 'Buy' Rating from Analysts

Analysts see upside potential in the healthcare real estate company's stock.

Mar. 27, 2026 at 9:24am

Got story updates? Submit your updates here. ›

PACS Group, Inc. (NYSE:PACS) has received a consensus 'Buy' rating from the six research firms currently covering the company, according to MarketBeat.com. One analyst has a 'Hold' rating, four have 'Buy' ratings, and one has a 'Strong Buy' rating on the stock. The average 12-month price target among analysts is $44.40.

Why it matters

The consensus 'Buy' rating and positive analyst sentiment suggest Wall Street sees upside potential in PACS Group's stock. As a healthcare real estate investment company, PACS Group's performance is closely tied to trends in the senior care and skilled nursing facility industries.

The details

Several analysts have recently weighed in on PACS Group. Wall Street Zen upgraded the stock from 'Hold' to 'Buy', while Truist Financial, JPMorgan Chase, and UBS Group have all assigned 'Buy' or 'Overweight' ratings and price targets ranging from $40 to $44.

  • PACS Group's stock has a 1-year low of $7.50 and a 1-year high of $43.08.
  • The company's 50-day moving average is $36.38 and its 200-day moving average is $27.31.

The players

PACS Group, Inc.

A healthcare real estate investment company that owns and operates skilled nursing facilities and assisted living facilities in the United States.

Wall Street Zen

An equity research firm that recently upgraded PACS Group's stock from 'Hold' to 'Buy'.

Truist Financial

A financial services company that has assigned a 'Buy' rating and $40 price target on PACS Group.

JPMorgan Chase & Co.

A global financial services firm that initiated coverage of PACS Group with an 'Overweight' rating and $44 price target.

UBS Group

A Swiss multinational investment bank that boosted its price target on PACS Group to $44 and maintained a 'Buy' rating.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

The takeaway

The consensus 'Buy' rating and positive analyst sentiment on PACS Group suggest Wall Street sees upside potential in the healthcare real estate company's stock, reflecting broader trends in the senior care and skilled nursing facility industries.